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Abstract 
Background: The nucleotide-binding oligomerisaton protein 2 (NOD2) constitutes a pivotal sensor of bacterial 
muramyl dipeptide and assures expression of distinct antimicrobial peptides and mediators produced by enterocytes 
and immune cells directed against pathogens including Campylobacter jejuni. We here elucidated the role of NOD2 
during murine C. jejuni infection in more detail.
Results: Conventionally colonized NOD2 deficient (NOD2−/−) mice and corresponding wildtype (WT) counterparts 
were perorally infected with C. jejuni strain 81–176 on three consecutive days. The pathogen colonized both WT and 
NOD2−/− mice only sporadically until day 14 post infection (p.i.). However, the slightly higher prevalence of C. jejuni 
in NOD2−/− mice was accompanied by higher intestinal Escherichia coli loads known to facilitate C. jejuni coloniza-
tion. Neither overt macroscopic (clinical) nor microscopic sequelae (such as colonic epithelial apoptosis) could be 
observed upon murine C. jejuni infection of either genotype. Innate immune responses were less distinctly induced 
in C. jejuni infected NOD2−/− versus WT mice as indicated by lower colonic numbers of neutrophils in the former. 
Conversely, adaptive immune cell counts including T lymphocytes were higher in large intestines of NOD2−/− as com-
pared to WT mice that were paralleled by increased colonic IL-6 secretion and higher TNF and IL-18 mRNA expression 
levels in large intestines of the former. Only in NOD2−/− mice, however, colonic IL-22 mRNA expression was down-
regulated at day 14 p.i. Whereas viable commensal intestinal bacteria could exclusively be detected in mesenteric 
lymph nodes and livers of NOD2−/− mice, bacterial translocation rates to kidneys and spleen were NOD2 independ-
ent. Notably, large intestinal mRNA expression levels of mucin-2, constituting a pivotal factor involved in epithelial 
barrier integrity, were comparable in naive and C. jejuni infected mice of either genotype.
Conclusion: NOD2 is involved in the well-balanced regulation of innate and adaptive pro-inflammatory immune 
responses of conventional mice upon C. jejuni infection.
Keywords: Campylobacter jejuni, Nucleotide-oligomerization-domain-2 (NOD2), In vivo infection, Intestinal 
microbiota, Colonization resistance, IL-23/IL-22/IL-18 axis, Pro-inflammatory immune responses, Bacterial translocation
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Background
Human Campylobacter infections are currently on the 
rise as indicated by increased prevalence and incidence 
rates in developed as well as developing countries [1, 
2]. C. jejuni colonizes the intestinal tract of wild and 
domestic animals as a commensal, whereas humans 
usually become perorally infected by consumption of 
contaminated products derived from livestock animals 
or of surface water [3, 4]. Infected patients complain 
about gastroenteritis of varying degree ranging from 
mild malaise with watery diarrhea to severe ulcerative 
colitis with abdominal cramps, fever and inflammatory, 
bloody diarrhea [2, 5]. In the vast majority of cases, dis-
ease resolves spontaneously, whereas post-infectious 
sequelae affecting the nervous system (i.e. Guillain-
Barré syndrome, Miller-Fisher syndrome and Bickerstaff 
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encephalitis), the joints (i.e. reactive polyarthritis) or 
the intestinal tract (i.e. irritable bowel syndrome) might 
arise in rare cases with a latency of weeks to months 
[2, 5, 6]. Susceptibility of vertebrates to Campylobacter 
infections is highly depending on the host specific intes-
tinal microbiota composition conferring physiological 
colonization resistance [7, 8]. Whereas conventionally 
colonized mice expell the pathogen from their intestinal 
tract within a few days following peroral C. jejuni chal-
lenge, modification of the murine intestinal microbiota 
by antibiotic treatment and reassociation with a human 
intestinal microbiota, for instance, results in stable path-
ogenic infection and, subsequently, distinct pro-inflam-
matory responses mimicking key features of human 
campylobacteriosis [7, 9] C. jejuni infection was further 
facilitated by pathophysiological conditions associated 
with increased intestinal commensal enterobacterial 
(i.e. E. coli) loads including acute and chronic intesti-
nal inflammation and obesity [10, 11]. Also 3-weeks-
old infant mice (immediately after weaning) harbored 
approximately two orders of magnitude higher intestinal 
commensal E. coli loads as compared to adult animals 
and were susceptible to C. jejuni infection, whereas the 
latter were not [12, 13]. In line with these results, arti-
ficial elevation of the intestinal E. coli loads in conven-
tional adult mice by feeding a viable commensal E. coli 
strain via the drinking water was sufficient to override 
colonization resistance and resulted in stable pathogenic 
infecton upon peroral challenge [10].
The nucleotide-binding oligomerization domain 
(NOD) like receptors comprize intracellular pattern rec-
ognition receptors that regulate host immunity by sens-
ing microbial products and damage-associated factors 
[14]. Among these, NOD2 is encoded by the card15 gene 
and expressed at different levels by Paneth cells [15] and 
innate (dendritic cells, macrophages) as well as adaptive 
(i.e. T lymphocytes) immune cell populations [16–18]. 
Muramyl dipeptide (MDP) is a major constituent of bac-
terial peptidoglycan that is well-known for its adjuvant 
and immunomodulatory properties [19]. Furthermore, 
MDP from virtually all Gram-positive and Gram-negative 
bacteria can activate NOD2 conferring resistance against 
a plethora of bacterial species [14, 20–22]. Whether 
NOD2 is also capable of sensing other microbial struc-
tures or participates as a mere signaling partner is under 
current debate [23].
In the present study we addressed the role of NOD2 
in C. jejuni infection of mice harboring a conventional 
intestinal microbiota and surveyed potential C. jejuni 
induced NOD2 dependent pro-inflammatory sequelae 
and bacterial translocation from the commensal intesti-
nal microbiota to extra-intestinal compartments.
Methods
Ethics statement
All animal experiments were conducted according to the 
European Guidelines for animal welfare (2010/63/EU) 
with approval of the commission for animal experiments 
headed by the “Landesamt für Gesundheit und Soziales” 
(LaGeSo, Berlin, registration number G0135/10). Animal 
welfare was monitored twice daily by assessment of clini-
cal conditions.
Mice and C. jejuni infection
NOD2−/− mice (in C57BL/6j background; initially 
obtained from The Jackson Laboratories, Bar Harbor, 
USA) and sex- and age-matched wildtype (WT) counter-
parts were bred, raised and maintained within the same 
specific pathogen free (SPF) unit in the Forschungsein-
richtungen für Experimentelle Medizin (FEM, Charité-
University Medicine Berlin). At the age of 3  months, 
female mice were perorally infected with 109 colony 
forming units (CFU) of viable C. jejuni strain 81–176 in a 
volume of 0.3 mL phosphate buffered saline (PBS; Gibco, 
life technologies, Paisley, UK) on three consecutive days 
(days 0, 1 and 2) by gavage as described earlier [7].
Sampling procedures
Mice were sacrificed at day 14 post infection (p.i.) by iso-
fluran treatment (Abbott, Greifswald, Germany). Ex vivo 
biopsies from mesenteric lymph nodes (MLN), spleen, 
liver, kidney and the gastrointestinal tract (i.e. stomach, 
duodenum, ileum and colon) were asserved under ster-
ile conditions. Colonic samples were collected in paral-
lel for microbiological and immunological analyses. For 
immunohistological analyses, colonic ex  vivo biopsies 
were immediately fixed in 5% formalin and embedded in 
paraffin.
Quantitative analysis of bacterial colonization 
and translocation
For bacterial quantification within the gastrointestinal 
tract feces was taken over time p.i. and luminal samples 
were derived from stomach, duodenum, ileum and colon 
at necropsy (day 14 p.i.) and dissolved in sterile PBS. For 
determination of C. jejuni loads, serial dilutions were cul-
tured on Columbia-Agar supplemented with 5% sheep 
blood and Karmali-Agar (both Oxoid, Wesel, Germany) 
for two days at 37 °C under microaerobic conditions using 
CampyGen gas packs (Oxoid). For quantification of E. 
coli, serial dilutions were cultured on Columbia-Agar sup-
plemented with 5% sheep blood and Mac Conkey Agar 
(both Oxoid) in aerobic atmosphere for two days at 37 °C.
Translocation of commensal intestinal bacteria to 
extra-intestinal compartments was quantitatively 
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assessed in respective organ homogenates under aero-
bic, microaerobic and obligate anaerobic conditions as 
described earlier [24–26].
The respective weights of fecal or tissue samples were 
determined by the difference of the sample weights 
before and after asservation. The detection limit of viable 
pathogens was ≈100 CFU per g.
Immunohistochemistry
Five µm thin paraffin sections of colonic ex vivo biopsies 
were subjected to in  situ immunohistochemical analysis 
as described previously [27–29]. In brief, primary anti-
bodies against cleaved caspase-3 (Asp175, Cell Signaling, 
Boston, MA, USA, 1:200), Ki67 (TEC3; Dako, Glostrup, 
Denmark; 1:100), CD3 (#N1580; Dako; 1:10), FOXP3 
(FJK-16  s; eBioscience, San Diego, CA, USA; 1:100), 
B220 (eBioscience; 1:200) and myeloperoxidase (MPO-
7, # A0398; Dako; 1:500) were used to assess apoptotic 
cells, proliferating/regenerating cells, T lymphocytes, 
regulatory T cells (Treg), B lymphocytes and neutro-
phils, respectively. The average number of positively 
stained cells within at least six high power fields (HPF, 
0.287 mm2; 400× magnification) were determined by an 
independent and blinded investigator.
Cytokine detection in supernatants of colonic ex vivo 
biopsies
Colonic ex  vivo biopsies were cut longitudinally and 
washed in PBS. Strips of approximately 1  cm2 large 
intestinal tissues were placed in 24-flat-bottom well cul-
ture plates (Nunc, Wiesbaden, Germany) containing 
500 μL serum-free RPMI 1640 medium (Gibco) supple-
mented with penicillin (100 U/mL) and streptomycin 
(100  µg/mL; PAA Laboratories, Cölbe, Germany). After 
18  h at 37  °C culture supernatants were tested for IL-6 
and IL-10 by the Mouse Inflammation Cytometric Bead 
Assay (CBA; BD Biosciences, Heidelberg, Germany) on 
a BD FACSCanto II flow cytometer (BD Biosciences) as 
described previously [30].
Real‑time PCR
RNA was isolated from snap frozen colonic ex vivo biop-
sies, reverse transcribed and analyzed as described pre-
viously [31]. Murine TNF, IFN-γ, IL-23p19, IL-22, IL-18 
and mucin-2 mRNA expression levels were detected by 
real-time PCR with specific primers and quantified by 
analysis with the Light Cycler Data Analysis Software 
(Roche Life Science, Mannheim, Germany). The mRNA 
of the housekeeping gene for hypoxanthine-phosphori-
bosyltransferase (HPRT) was used as reference, and the 
mRNA expression levels of the individual genes were 
normalized to the lowest measured value and expressed 
as fold expression (Arbitrary Units).
Statistical analysis
Medians and levels of significance were determined using 
the Mann–Whitney U test (GraphPad Prism v5, La Jolla, 
CA, USA) as indicated. Two-sided probability (p) val-
ues ≤0.05 were considered significant.
Results
Pathogenic colonization properties in C. jejuni infected 
conventionally colonized NOD2−/− mice
In order to investigate the role of NOD2 during C. jejuni 
infection of mice harboring a conventional microbiota, 
NOD2−/− and corresponding WT control mice were 
perorally infected with 109 CFU C. jejuni strain 81–176 
on three consecutive days (days 0, 1 and 2). Within 
24 h following the latest infection viable C. jejuni could 
be detected in 60.0% of fecal samples derived from 
NOD2−/− mice with low median loads of approximately 
102 CFU per g feces only (Fig. 1a; Additional file 1: Figure 
Fig. 1 Gastrointestinal C. jejuni loads in perorally infected conven-
tionally colonized NOD2−/− mice. Wildtype (WT; white circles) and 
NOD2−/− mice (black circles) were perorally infected with C. jejuni 
strain 81–176 on three consecutive days (d0, 1 and 2). a Pathogenic 
colonization densities were assessed in fecal samples (CFU, colony 
forming units per gram) over time post infection (p.i.). b At day of 
necrosy (d14 p.i.) C. jejuni loads were determined in luminal samples 
derived from distinct parts of the gastrointestinal tract. Medians 
(black bars) are indicated and numbers of mice harboring C. jejuni 
strain 81-176 out of the total number of analyzed animals are given in 
parentheses. Data were pooled from four independent experiments
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S1). More than half of WT mice, however, had expelled 
the pathogen from their intestinal tract in the meantime, 
given that C. jejuni could be isolated in only 43.8% of 
feces derived from WT mice with median loads below the 
detection limit (Fig. 1a; Additional file 1: Figure S1). Later 
during the course of infection pathogenic loads further 
declined in mice of either genotype with 20.0 and 6.3% 
of NOD2−/− and WT mice, respectively, harboring C. 
jejuni in their feces at day 14 p.i. (Fig. 1; Additional file 1: 
Figure S1). Despite higher pathogenic positivity rates in 
NOD2−/− vs WT mice, intestinal C. jejuni loads did not 
differ at defined time points p.i. (n.s; Fig.  1a). At day of 
necropsy (i.e. day 14 p.i.), C. jejuni could be isolated from 
the stomach, proximal and distal small intestines as well 
as the colon in single cases only (n.s.; Fig. 1b).
Given that elevated intestinal loads of commensal E. 
coli facilitate C. jejuni colonization [10], we next assessed 
fecal E. coli densities in NOD2−/− and WT mice imme-
diately before and 14 days after C. jejuni infection. Naive 
and infected NOD2−/− mice exhibited approximately 0.5 
and 1.0 log, respectively, higher fecal E. coli densities as 
compared to respective WT counterparts (p <  0.05 and 
p < 0.001, respectively; Fig. 2a). Within 14 days following 
pathogenic challenge, E. coli loads declined by less than 
one order of magnitude in fecal samples of WT mice 
(p < 0.01; Fig. 2a). At day of necropsy, E. coli loads were 
up to two orders of magnitude higher in luminal samples 
taken from the stomach, duodenum, ileum and colon of 
NOD2−/− as compared to WT mice (p  <  0.005–0.001; 
Fig. 2b). Taken together, NOD2 deficiency did not impact 
gastrointestinal colonization properties of C. jejuni in 
conventionally colonized mice. Slightly higher percent-
ages of C. jejuni infected NOD2−/− mice were associated 
with higher commensal intestinal E. coli loads as com-
pared to WT controls.
Microscopic sequelae and pro‑inflammatory cell responses 
upon C. jejuni infection of conventional NOD2−/− mice
Following C. jejuni infection mice of either genotype 
were virtually uncompromized from their clinical aspect. 
Given that apoptosis comprizes a valuable marker for 
the histopathological grading of intestinal inflamma-
tion and is a key feature of campylobacteriosis [7], we 
next stained colonic paraffin sections of infected mice 
against caspase-3 by in  situ immunohistochemistry. As 
for the macroscopic aspect, no changes in numbers of 
apoptotic cells in colonic epithelia could be observed 
at day 14 following C. jejuni infection of mice irrespec-
tive of their genotype (n.s.; Fig.  3a). We also performed 
in situ immunhistochemical stainings of colonic sections 
against the proliferation marker Ki67. Interestingly, naive 
NOD2−/− mice exhibited approximately one-third lower 
numbers of Ki67+ colonic epithelial cells as compared to 
WT controls (p < 0.05; Fig. 3b), whereas large intestinal 
proliferating cell numbers declined by more than one-
third in WT, but not NOD2−/− mice until day 14 follow-
ing C. jejuni infection (p < 0.05; Fig. 3b).
Given that recruitment of pro-inflammatory immune 
cells to the site of infection is a hall mark of intesti-
nal inflammation including campylobacteriosis [7], we 
next quantitatively assessed distinct innate and adaptive 
immune cell populations in the large intestinal mucosa 
and lamina propria of infected mice applying in  situ 
immunohistochemistry. At day 14 p.i., colonic T lympho-
cyte numbers were higher in NOD2−/− as compared to 
WT mice (p < 0.005; Fig. 4a). Following C. jejuni infec-
tion Treg numbers increased in the large intestines of 
NOD2−/−, but not WT mice (p < 0.01; Fig. 4b). Notably, 
under naive conditions colonic Treg numbers were lower 
in NOD2−/− as compared to WT mice (p < 0.01; Fig. 4b). 
Fig. 2 Commensal intestinal E. coli loads in C. jejuni infected conven-
tionally colonized NOD2−/− mice. Wildtype (WT; white circles) and 
NOD2−/− mice (black circles) were perorally infected with C. jejuni 
strain 81–176 on three consecutive days (d0, 1 and 2). Commensal E. 
coli loads were compared (a) in feces immediately before infection 
(d0) and 14 days thereafter and determined (b) in luminal samples 
derived from the gastrointestinal tract at day 14 following C. jejuni 
challenge. Medians (black bars) and levels of significance (p values) 
determined by Mann–Whitney U test are indicated. Numbers of mice 
harboring commensal E. coli out of the total number of analyzed 
animals are given in parentheses. Data were pooled from four inde-
pendent experiments
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Whereas upon C. jejuni infection colonic B lymphocytes 
were elevated in WT mice only (p < 0.05; Fig. 4c), neu-
trophil numbers increased in the large intestinal mucosa 
and lamina propria of both WT and NOD2−/− at day 14 
p.i. (p < 0.001 and p < 0.05, respectively; Fig. 4d), but to a 
lesser extent in the latter (p < 0.005; Fig. 4d).
Pro‑ and anti‑inflammatory cytokine responses upon C. 
jejuni infection of conventional NOD2−/− mice
We next measured secretion of the pro-inflammatory 
cytokine IL-6 and the anti-inflammatory mediator IL-10 
in colonic ex  vivo biopsies. Whereas colonic IL-6 lev-
els increased in C. jejuni infected NOD2−/− mice only 
(p  <  0.05; Fig.  5a), IL-10 concentrations were higher in 
the large intestines of WT (p  <  0.01; Fig.  5b), but not 
NOD2−/− mice at day 14 p.i. as compared to naive con-
trols. We further analyzed colonic expression levels of the 
pro-inflammatory cytokines TNF and IFN-γ. At day 14 
p.i., increased mRNA levels of either pro-inflammatory 
mediator could be determined in colonic ex vivo biopsies 
of both NOD2−/− and WT mice (p < 0.05 – 0.001; Fig. 5c, 
d). Interestingly, the C. jejuni induced TNF up-regulation 
was more pronounced in infected NOD2−/− as compared 
to WT mice (p  <  0.001; Fig.  5c). Moreover, also in the 
naive state, TNF mRNA levels were higher in NOD2−/− 
than WT mice (p < 0.005; Fig. 5c).
Our group could recently show that the IL-23/IL-22/
IL-18 axis is involved in mediating murine C. jejuni infec-
tion [32–36]. We therefore determined potential NOD2 
dependent mRNA expression of respective mediators 
during murine C. jejuni infection. Whereas colonic IL-
23p19 mRNA levels did not differ in naive and infected 
mice of either genotype (n.s.; Fig. 6a), IL-22 mRNA was 
down-regulated in large intestines of infected WT mice 
only (p  <  0.05; Fig.  5b), whereas colonic IL-18 mRNA 
expression levels were higher in infected NOD2−/− as 
compared to WT mice at day 14 p.i. (p  <  0.05; Fig. 5c). 
Notably, IL-22 mRNA levels were lower in naive 
NOD2−/− than WT mice (p  <  0.005; Fig.  5b). Hence, 
large intestinal IL-6 secretion as well as TNF and IL-18 
mRNA levels were higher in NOD2−/− as compared to 
WT mice upon pathogenic infection, whereas C. jejuni 
induced colonic IL-22 down-regulation occurred in WT 
mice only.
Translocation of intestinal commensal species 
to extra‑intestinal compartments following C. jejuni 
infection of conventional NOD2−/− mice
We next addressed whether C. jejuni infection was asso-
ciated with translocation of viable bacteria originating 
from the commensal intestinal microbiota to MLN and 
extra-intestinal compartments. Notably, in naive mice 
Fig. 3 Apoptotic and proliferating cells in the colonic epithelium of C. jejuni infected conventionally colonized NOD2−/− mice. Wildtype (WT; white 
circles) and NOD2−/− mice (black circles) were perorally infected with C. jejuni strain 81–176 on three consecutive days (d0, 1 and 2). The average 
number of colonic (a) apoptotic cells (positive for caspase-3, Casp3) and (b) proliferating cells (positive for Ki67) from six high power fields (HPF, 
400× magnification) per animal was determined microscopically in immunohistochemically stained colonic paraffin sections at day 14 following C. 
jejuni infection. Naive (N) mice served as uninfected controls. Medians (black bars), levels of significance (p values) determined by Mann–Whitney U 
test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four independent experiments
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Fig. 4 Colonic immune cell responses in C. jejuni infected conventionally colonized NOD2−/− mice. Wildtype (WT; white circles) and NOD2−/− mice 
(black circles) were perorally infected with C. jejuni strain 81–176 on three consecutive days (d0, 1 and 2). The average number of colonic a T lympho-
cytes (positive for CD3) b regulatory T cells (Treg, positive for FOXP3) c B lymphocytes (positive for B220) and d neutrophils (positive for MPO7) from 
six high power fields (HPF, 400× magnification) per animal was determined microscopically in immunohistochemically stained colonic paraffin 
sections at day 14 following C. jejuni infection. Naive (N) mice served as uninfected controls. Medians (black bars), levels of significance (p values) 
determined by Mann–Whitney U test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four independent 
experiments
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Fig. 5 Colonic cytokines in C. jejuni infected conventionally colonized NOD2−/− mice. Wildtype (WT; white circles) and NOD2−/− mice (black circles) 
were perorally infected with C. jejuni strain 81–176 on three consecutive days (d0, 1 and 2). a IL-6 and b IL-10 protein concentrations were measured 
in colonic ex vivo biopsies at day 14 post infection. In additon, large intestinal c TNF and d IFN-γ mRNA expression levels were determined by real 
time PCR and expressed as arbitrary units (fold expression). Naive (N) mice served as uninfected controls. Medians (black bars), levels of significance 
(p value) determined by Mann–Whitney U test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four inde-
pendent experiments
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all organ homogenates were free of viable bacteria (not 
shown). Whereas no bacteria could be detected in MLN 
and liver homogenates of WT mice at day 14 p.i., com-
mensal intestinal bacterial species were isolated from 
40.0% of MLN and 20.0% of liver samples derived from C. 
jejuni infected NOD2−/− mice by direct plating (Fig. 7). 
Bacterial translocation rates into spleens were 25.0 and 
20.0% in WT and NOD2−/− mice, respectively, whereas 
commensal bacterial species could be isolated in 12.5 and 
20.0% of kidneys taken from WT and NOD2−/− mice, 
respectively, at day 14 p.i. (Fig.  7). In culture-positive 
cases, intestinal commensals such as E. coli, Enterococcus 
spp. and/or Lactobacillus spp. could be isolated.
Mucin-2 (MUC-2) constitutes a pivotal component of 
the mucus layer covering the intestinal epithelium and 
thereby combats bacterial infections and maintains epi-
thelial barrier integrity [37, 38]. We therefore raised the 
question whether mucin-2 expression was affected in 
NOD2−/− mice thereby facilitating bacterial transloca-
tion. Neither under naive conditions nor at day 14 fol-
lowing C. jejuni infection, however, mucin-2 mRNA 
expression levels differed in the colon of NOD2−/− and 
WT mice (n.s.; Additional file 2: Figure S2).
Discussion
The well-orchestrated interaction of distinct immune 
cells, pattern recognition receptors and evolving signal-
ing pathways is pivotal to prevent the vertebrate host 
from infections with invading pathogens including C. 
jejuni. In the present study we investigated the impact of 
the bacterial MDP sensor NOD2 during C. jejuni infec-
tion of conventionally colonized mice. Despite peroral 
challenge with high pathogenic loads even on three con-
secutive days, both WT and NOD2−/− could be colo-
nized only sporadically until day 14 p.i., which is due to 
the physiological colonization resistance mediated by the 
distinct murine microbiota composition [7, 9, 12, 13, 34, 
39, 40]. During the entire time course following infection 
pathogenic positivity rates of fecal samples were slightly 
higher in NOD2−/− as compared to WT mice. This might 
be explained by concomitant slightly higher loads of 
Fig. 6 Colonic expression of IL-23p19, IL-22 and IL-18 mRNA in C. jejuni infected conventionally colonized NOD2−/− mice. Wildtype (WT; white cir-
cles) and NOD2−/− mice (black circles) were perorally infected with C. jejuni strain 81–176 on three consecutive days (d0, 1, and 2). a IL-23p19 b IL-22 
and c IL-18 mRNA expression levels were determined in colonic ex vivo biopsies at day 14 post infection by real time PCR and expressed as arbitrary 
units (fold expression). Naive (N) mice served as uninfected controls. Medians (black bars), levels of significance (p value) determined by Mann–Whit-
ney U test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four independent experiments
Fig. 7 Pathogenic translocation in C. jejuni infected conventionally 
colonized NOD2−/− mice. Wildtype (WT; white bars) and NOD2−/− 
mice (black bars) were perorally infected with C. jejuni strain 81–176 
on three consecutive days (d0, 1 and 2). Translocation of viable 
pathogens were assessed in ex vivo biopsies derived from mesenteric 
lymph nodes (MLN), spleen, liver and kidney at day 14 post infection 
by culture. Relative abundances of viable pathogens in respective 
compartments are shown (bars; in %) and numbers of mice harboring 
C. jejuni out of the total number of analyzed animals (in parentheses) 
are indicated. Data shown are representative for two independent 
experiments
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commensal E. coli (between one and two orders of mag-
nitude) within the gastrointestinal lumen known to facili-
tate C. jejuni colonization [7, 8, 10, 12, 13, 34, 39, 40]. In 
addition, NOD2 deficiency is associated with defective 
expression of antimicrobial peptides resulting in compro-
mized pathogenic clearance by the host [41, 42].
Several studies further revealed the importance of 
NOD2 in sensing and elimination of pathogens, given 
that NOD2−/− mice have been shown to be more suscep-
tible to infection with Salmonella Typhimurium [43] or 
Listeria monocytogenes [42]. A previous elegant in  vivo 
study revealed that NOD2 is essential for the control 
of campylobacteriosis in antibiotics-treated mice lack-
ing IL-10 [44]. Interestingly, C. jejuni induced colitis 
was more pronounced in NOD2−/− IL-10−/− mice as 
compared to IL-10−/− mice. The authors further dem-
onstrated that NOD2 was essential for nitric oxide pro-
duction in peritoneal macrophages. Based on the finding 
that nitroprusside attenuated murine campylobacte-
riosis the authors concluded that NOD2 is essential for 
pathogen control by bactericidal responses involving 
nitric oxide [44]. Differences regarding disease outcomes 
when compared to our report are due to substantial dif-
ferences regarding the applied animal models. Whereas 
Su and colleagues had pretreated IL-10−/− mice with 
broad-spectrum antibiotics prior C. jejuni infection, we 
here investigated WT animals harboring a conventional 
microbiota.
In line with our previous reports, also in the present 
study C. jejuni infected conventionally colonized mice of 
either genotype were neither clinically compromized (by 
wasting or abundance of bloody diarrhea, for instance), 
nor could microscopic sequelae such as colonic epithe-
lial apoptosis be observed at necropsy [7–9, 30]. One 
could assume that lack of overt pathological responses 
might be due to successful clearance of the enteropatho-
gen during the course of infection by the host. As shown 
earlier, however, C. jejuni does not necessarily need to 
permanently establish witin the intestinal tract to evoke 
pro-inflammatory host responses [30, 32, 36, 45]. It is 
rather the initial hit of the enteropathogenic infection 
that tips the balance towards immunopathological host 
responses [30]. In support of this hypothesis, C. jejuni 
induced large intestinal immune cell responses could, in 
fact, be observed also in the present study as indicated 
by elevated Treg numbers in infected NOD2−/− mice 
only, whereas B lymphocytes increased exclusively in the 
large intestines of WT mice. In addition, innate immune 
responses were more pronounced in NOD2 deficient 
mice as indicated by an increased influx of neutrophils 
into the colonic mucosa and lamina propria following C. 
jejuni infection that was more pronounced in NOD2−/− 
as compared to WT mice and paralleled by higher levels 
of pro-inflammatory cytokines including IL-6 and TNF. 
Conversely, colonic concentrations of the anti-inflam-
matory cytokine IL-10 was elevated in WT, but not 
NOD2−/− mice at day 14 p.i., further supporting the 
overall more pronounced C. jejuni induced pro-inflam-
matory host responses upon NOD2 deficiency.
Very recently our group has highlighted the impor-
tance of the IL-23/IL-22/IL-18 axis in campylobacte-
riosis [30, 32, 34, 36]. In infected secondary abiotic WT 
mice, for instance, colonic IL-23p19, IL-22 and IL-18 
were all upregulated [36], whereas large intestinal IL-22 
mRNA levels were shown to be increased in infected 
IL-10−/− mice [46]. As member of the IL-10 cytokine 
family, IL-22 can exert dichotomous modes of action 
depending on the respective tissue (i.e. compartment of 
the intestinal tract) and the surrounding cytokine milieu 
[30, 47, 48]. Whereas in the small intestines IL-22 exerts 
pro-inflammatory properties as shown in murine Toxo-
plasma gondii induced ileitis [31, 49, 50], IL-22 has anti-
inflammatory functions in the colon [48]. Interestingly, in 
the present study basal IL-22 mRNA levels were lower in 
large intestines of NOD2−/− as compared to WT mice. 
Given that IL-22 was shown to be effective in antimicro-
bial host defence against C. jejuni [51], down-regulated 
basal IL-22 levels might explain slightly higher fecal path-
ogenic positivity rates in NOD2−/− as compared to WT 
mice shown here. C. jejuni infection, however, resulted 
in down-regulation of colonic IL-22 expression in WT 
animals only, whereas neither IL-23p19 (as well-known 
master regulator of mucosal immune responses [52]) 
nor IL-18 (amplifying IL-22 production during intestinal 
inflammation [50]), were affected upon infection, which 
is well in line with our very recent results derived in C. 
jejuni infected conventional mice as well [30].
Epithelial barrier integrity is of utmost importance for 
limiting bacterial/pathogenic spread from the intesti-
nal compartment to extra-intestinal including systemic 
compartments with potentially fatal consequences for 
the host [53]. Whereas in the present study bacterial 
translocation could not be observed in any naive mice 
of both genotypes, viable commensal intestinal species 
such as E. coli, enterococci and/or lactobacilli could be 
exclusively detected in MLN and livers of NOD2−/− 
mice, whereas bacterial translocation rates to kidney 
and spleen were rather comparable. Given that mucins 
including MUC-2 are pivotal components of the viscous 
mucous layer preserving epithelial barrier function by 
protecting the underlying mucosal epithelial layer not 
only from invading pathogens, but also from translocat-
ing intestinal commensals [53, 54], we analyzed MUC-2 
expression in the colon of NOD2−/− and WT mice 
before and 14  days after C. jejuni infection. We could, 
however, not observe significant differences in colonic 
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MUC-2 expression that might explain the observed dif-
ferences in bacterial translocation rates. One needs to 
take into consideration that epithelial barrier function is 
warranted by a complex interaction of many independ-
ent factors (with MUC-2 mRNA expression only one 
amongst plenty) [55].
We conclude that NOD2 is involved in the well-bal-
anced regulation of innate and adaptive pro-inflamma-
tory immune responses of conventional mice upon C. 
jejuni infection. Future studies are needed to unravel the 
underlying molecular mechanisms in more detail.
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